Artificial intelligence (AI) is on pace to become the most rapidly adopted technology in health care, fundamentally transforming oncology. This podcast explores the five critical ways AI is already influencing cancer care.

We detail how AI is enhancing diagnostics by improving imaging accuracy and enabling digital pathology systems for primary diagnosis. Learn how AI acts as a "copilot" in precision oncology, integrating multimodal data—including imaging, pathology, and genomic results—to guide treatment selection and predict adverse events. AI is also essential in managing the volume of new research, offering tools that give oncologists faster, interactive access to clinical guidelines and help find and interpret medical studies.

Furthermore, we look at how AI is streamlining the clinical trial process by quickly identifying eligible patients from structured and unstructured data, leading to faster recruitment. Finally, explore patient-facing AI tools that help individuals understand their treatment options, access clinical trials, and organize their records. Despite wariness from some clinicians and patients who cite concerns about depersonalization and privacy, investors are committed, with significant investment surging into AI for drug discovery and digital health. AI is rapidly becoming an integral part of nearly every step in cancer care.

Interested in learning more about the financial side? We can delve into the surge of investment dollars driving AI drug discovery and digital health, or explore how regulatory bodies are formally recognizing AI's role in drug development and medical devices.